These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 20408548)
1. Structural evidence that human acetylcholinesterase inhibited by tabun ages through O-dealkylation. Carletti E; Colletier JP; Dupeux F; Trovaslet M; Masson P; Nachon F J Med Chem; 2010 May; 53(10):4002-8. PubMed ID: 20408548 [TBL] [Abstract][Full Text] [Related]
2. Aging of cholinesterases phosphylated by tabun proceeds through O-dealkylation. Carletti E; Li H; Li B; Ekström F; Nicolet Y; Loiodice M; Gillon E; Froment MT; Lockridge O; Schopfer LM; Masson P; Nachon F J Am Chem Soc; 2008 Nov; 130(47):16011-20. PubMed ID: 18975951 [TBL] [Abstract][Full Text] [Related]
3. Structural changes of phenylalanine 338 and histidine 447 revealed by the crystal structures of tabun-inhibited murine acetylcholinesterase. Ekström F; Akfur C; Tunemalm AK; Lundberg S Biochemistry; 2006 Jan; 45(1):74-81. PubMed ID: 16388582 [TBL] [Abstract][Full Text] [Related]
4. Structure-activity analysis of aging and reactivation of human butyrylcholinesterase inhibited by analogues of tabun. Carletti E; Aurbek N; Gillon E; Loiodice M; Nicolet Y; Fontecilla-Camps JC; Masson P; Thiermann H; Nachon F; Worek F Biochem J; 2009 Jun; 421(1):97-106. PubMed ID: 19368529 [TBL] [Abstract][Full Text] [Related]
5. Novel nerve-agent antidote design based on crystallographic and mass spectrometric analyses of tabun-conjugated acetylcholinesterase in complex with antidotes. Ekström FJ; Astot C; Pang YP Clin Pharmacol Ther; 2007 Sep; 82(3):282-93. PubMed ID: 17443135 [TBL] [Abstract][Full Text] [Related]
6. Structural approach to the aging of phosphylated cholinesterases. Masson P; Nachon F; Lockridge O Chem Biol Interact; 2010 Sep; 187(1-3):157-62. PubMed ID: 20338153 [TBL] [Abstract][Full Text] [Related]
7. Chromatographic preparation and kinetic analysis of interactions between tabun enantiomers and acetylcholinesterase. Tenberken O; Thiermann H; Worek F; Reiter G Toxicol Lett; 2010 Jun; 195(2-3):142-6. PubMed ID: 20347021 [TBL] [Abstract][Full Text] [Related]
8. Crystal structures of acetylcholinesterase in complex with HI-6, Ortho-7 and obidoxime: structural basis for differences in the ability to reactivate tabun conjugates. Ekström F; Pang YP; Boman M; Artursson E; Akfur C; Börjegren S Biochem Pharmacol; 2006 Aug; 72(5):597-607. PubMed ID: 16876764 [TBL] [Abstract][Full Text] [Related]
9. Reactivation of tabun-hAChE investigated by structurally analogous oximes and mutagenesis. Artursson E; Akfur C; Hörnberg A; Worek F; Ekström F Toxicology; 2009 Nov; 265(3):108-14. PubMed ID: 19761810 [TBL] [Abstract][Full Text] [Related]
11. Aging mechanism of butyrylcholinesterase inhibited by an N-methyl analogue of tabun: implications of the trigonal-bipyramidal transition state rearrangement for the phosphylation or reactivation of cholinesterases. Nachon F; Carletti E; Worek F; Masson P Chem Biol Interact; 2010 Sep; 187(1-3):44-8. PubMed ID: 20381476 [TBL] [Abstract][Full Text] [Related]
12. Role of water in aging of human butyrylcholinesterase inhibited by echothiophate: the crystal structure suggests two alternative mechanisms of aging. Nachon F; Asojo OA; Borgstahl GE; Masson P; Lockridge O Biochemistry; 2005 Feb; 44(4):1154-62. PubMed ID: 15667209 [TBL] [Abstract][Full Text] [Related]
13. Aging pathways for organophosphate-inhibited human butyrylcholinesterase, including novel pathways for isomalathion, resolved by mass spectrometry. Li H; Schopfer LM; Nachon F; Froment MT; Masson P; Lockridge O Toxicol Sci; 2007 Nov; 100(1):136-45. PubMed ID: 17698511 [TBL] [Abstract][Full Text] [Related]
14. In silico pharmacophore model for tabun-inhibited acetylcholinesterase reactivators: a study of their stereoelectronic properties. Bhattacharjee AK; Kuca K; Musilek K; Gordon RK Chem Res Toxicol; 2010 Jan; 23(1):26-36. PubMed ID: 20028185 [TBL] [Abstract][Full Text] [Related]
15. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice. Kassa J; Karasova J; Musilek K; Kuca K Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821 [TBL] [Abstract][Full Text] [Related]
16. [A comparison of the efficacy of the reactivators of acetylcholinesterase inhibited with tabun]. Cabal J; Kuca K; Jun D; Bajgar J; Hrabinová M Ceska Slov Farm; 2005 Jul; 54(4):192-5. PubMed ID: 16124202 [TBL] [Abstract][Full Text] [Related]
17. Crystallographic snapshots of nonaged and aged conjugates of soman with acetylcholinesterase, and of a ternary complex of the aged conjugate with pralidoxime. Sanson B; Nachon F; Colletier JP; Froment MT; Toker L; Greenblatt HM; Sussman JL; Ashani Y; Masson P; Silman I; Weik M J Med Chem; 2009 Dec; 52(23):7593-603. PubMed ID: 19642642 [TBL] [Abstract][Full Text] [Related]
18. Kinetic analysis of reactivation and aging of human acetylcholinesterase inhibited by different phosphoramidates. Worek F; Aurbek N; Koller M; Becker C; Eyer P; Thiermann H Biochem Pharmacol; 2007 Jun; 73(11):1807-17. PubMed ID: 17382909 [TBL] [Abstract][Full Text] [Related]
19. A comparison of the efficacy of a bispyridinium oxime--1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods. Kuca K; Cabal J; Kassa J Pharmazie; 2004 Oct; 59(10):795-8. PubMed ID: 15544060 [TBL] [Abstract][Full Text] [Related]
20. Fixation of the two Tabun isomers in acetylcholinesterase: a QM/MM study. Kwasnieski O; Verdier L; Malacria M; Derat E J Phys Chem B; 2009 Jul; 113(29):10001-7. PubMed ID: 19569635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]